(1)
METABOLIC SYNDROME IN MADHUMEGAM (TYPE 2 DIABETES MELLITUS) PATIENTS REPORTING AT NATIONAL INSTITUTE OF SIDDHA – A CROSS SECTIONAL STUDY. Int J Ayu Pharm Res 2019, 7 (8), 35-40.